Skip to content
2000
Volume 22, Issue 10
  • ISSN: 1566-5240
  • E-ISSN: 1875-5666

Abstract

The coronavirus disease 2019 (COVID-19) is a contagious disease that is caused by a novel coronavirus. The human coronavirus (HCoV) is recognized as one of the most rapidly evolving viruses owing to its high genomic nucleotide substitution rates and recombination. Among the severe acute respiratory syndrome (SARS) and Middle- East respiratory syndrome (MERS), COVID-19 has spread more rapidly and increased the level of globalization and adaptation of the virus in every environmental condition due to their high rate of molecular diversity. The whole article highlights the general characteristics of coronavirus, their molecular diversity, and molecular protein targeting against COVID-19 with their newer approaches. Through this review, an attempt has been made to critically evaluate the recent advances and future aspects that are helpful to the treatment of COVID-19 based on the present understanding of SARS-CoV-2 infections, which may offer new insights and potential therapeutic targets for the treatment of COVID-19.

Loading

Article metrics loading...

/content/journals/cmm/10.2174/1566524021666210203113849
2022-12-01
2025-12-08
Loading full text...

Full text loading...

/content/journals/cmm/10.2174/1566524021666210203113849
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test